Photodynamic therapy of cancer using graphene nanomaterials

被引:1
|
作者
Tiwari, Sanjay [1 ]
Rudani, Binny A. [1 ]
Tiwari, Priyanka [1 ]
Bahadur, Pratap [2 ]
Flora, Swaran J. S. [3 ]
机构
[1] Natl Inst Pharmaceut Educ & Res NIPER Raebareli, Dept Pharmaceut, Lucknow 226002, UP, India
[2] Veer Narmad South Gujarat Univ, Dept Chem, Surat, India
[3] Era Lucknow Med Univ, Era Coll Pharm, Lucknow, India
关键词
Photosensitizer; near-infrared radiation; singlet oxygen; heteroatom doping; target selectivity; quantum yield; ENDOPLASMIC-RETICULUM STRESS; QUANTUM DOTS; CELL-DEATH; SINGLET OXYGEN; INDEPENDENT APOPTOSIS; OXIDE NANOPARTICLES; PEGYLATED GRAPHENE; DRUG-DELIVERY; PHOTOSENSITIZER; TUMOR;
D O I
10.1080/17425247.2024.2398604
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
IntroductionHigh incidence and fatality rates of cancer remain a global challenge. The success of conventional treatment modalities is being questioned on account of adverse effects. Photodynamic therapy (PDT) is a potential alternative. It utilizes a combination of photosensitizer (PS), light and oxygen to target the tissues locally, thereby minimizing the damage to neighboring healthy tissues. Conventional PSs suffer from poor selectivity, high hydrophobicity and sub-optimal yield of active radicals. Graphene nanomaterials (GNs) exhibit interesting particulate and photophysical properties in the context of their use in PDT. Area coveredWe focus on describing the mechanistic aspects of PDT-mediated elimination of cancer cells and the subsequent development of adaptive immunity. After covering up-to-date literature on the significant enhancement of PDT capability with GNs, we have discussed the probability of combining PDT with chemo-, immuno-, and photothermal therapy to make the treatment more effective. Expert opinionGNs can be synthesized in various size ranges, and their biocompatibility can be improved through surface functionalization and doping. These can be used as PS to generate ROS or conjugated with other PS molecules for treating deep-seated tumors. With increasing evidence on biosafety, such materials offer hope as antitumor therapeutics. GRAPHICAL ABSTRACT
引用
收藏
页码:1331 / 1348
页数:18
相关论文
共 50 条
  • [41] Tumor photothermolysis: using carbon nanomaterials for cancer therapy
    Sawdon, Alicia
    Weydemeyer, Ethan
    Peng, Ching-An
    EUROPEAN JOURNAL OF NANOMEDICINE, 2013, 5 (03) : 131 - 140
  • [42] Graphene-based nanomaterials and their potentials in advanced drug delivery and cancer therapy
    Liu, Jinzhao
    Dong, Jia
    Zhang, Ting
    Peng, Qiang
    JOURNAL OF CONTROLLED RELEASE, 2018, 286 : 64 - 73
  • [43] Heptamethine Cyanine-Loaded Nanomaterials for Cancer Immuno-Photothermal/Photodynamic Therapy: A Review
    Alves, Catia G.
    Lima-Sousa, Rita
    Melo, Bruna L.
    Moreira, Andre F.
    Correia, Ilidio J.
    de Melo-Diogo, Duarte
    PHARMACEUTICS, 2022, 14 (05)
  • [44] Photodynamic therapy for cancer
    Dolmans, DEJGJ
    Fukumura, D
    Jain, RK
    NATURE REVIEWS CANCER, 2003, 3 (05) : 380 - 387
  • [45] Multifunctional silica-based nanomaterials for biomedical applications: Photodynamic therapy and pancreatic cancer treatment
    Vivero-Escoto, Juan L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [46] Management of Cancer using Photodynamic Therapy: Advancement and Applications
    Yadav, Deepika
    Sharma, Pramod
    Mishra, Prem
    Malviya, Rishabha
    CURRENT CANCER THERAPY REVIEWS, 2024, 20 (04) : 357 - 371
  • [47] A comprehensive review on singlet oxygen generation in nanomaterials and conjugated polymers for photodynamic therapy in the treatment of cancer
    Singh, Neetika
    Sen Gupta, Ria
    Bose, Suryasarathi
    NANOSCALE, 2024, 16 (07) : 3243 - 3268
  • [48] Photodynamic therapy and cancer
    Brown, Stanley B.
    Ibbotson, Sally H.
    BRITISH MEDICAL JOURNAL, 2009, 339
  • [49] Photodynamic therapy for cancer
    Dennis E.J.G.J. Dolmans
    Dai Fukumura
    Rakesh K. Jain
    Nature Reviews Cancer, 2003, 3 : 380 - 387
  • [50] BREAST CANCER TISSUE TREATED USING PHOTODYNAMIC THERAPY
    Barnas, Edyta
    Ostanska, Elzbieta
    Bartusik-Aebisher, Dorota
    Dynarowicz, Klaudia
    Skret-Magierlo, Joanna
    Aebisher, David
    ACTA POLONIAE PHARMACEUTICA, 2021, 78 (06): : 835 - 843